Norvax® Vibriose Marine

Species

PRODUCT INFORMATION

DESCRIPTION
Inactivated trivalent vaccine against classical vibriosis for immersion or injection in Atlantic cod.

COMPOSITION
Inactivated strains of Listonella (Vibrio) anguillarum serovar O1 and Listonella (Vibrio) anguillarum serovar O2α and O2β.

FORMULATION
Water-based suspension for immersion or injection.

INDICATIONS
For active immunization of Atlantic cod to reduce mortality due to the disease vibriosis caused by Listonella (Vibrio) anguillarum serovars O1, O2α and O2β. It also provides cross-protection against Vibrio ordalii.

DOSAGE

Immersion:
1 litre is sufficient for 100 kg of 5- to 10-gram fry. Immerse the fish in a 1:10 vaccine dilution for 30 seconds.

Injection: For fish above 30 grams, 0.1 ml is injected intraperitoneally along the central line, 0.5 - 1.0 fin length in front of the pelvic fin base. Ensure the recommended dose is deposited into the abdominal cavity before the needle is withdrawn. The length and diameter of the needle should be adapted to the actual fish size.

WITHHOLDING PERIOD
Nil. (National regulations should be observed).

PRESENTATION
Norvax® Vibriose Marine is available in 500-ml PET bottles.

STORAGE
Store between 2 and 8°C. Do not freeze. Once opened, bottles should be used the same day. Don't use after the expiry date.

CONTRA-INDICATIONS
None

FURTHER INFORMATION
Fish should be withheld from feed for 1-2 days before vaccination. Fish should be anaesthetised according to veterinary recommendations. Start feeding, at the earliest, 12 hours after vaccination. Only healthy fish should be vaccinated. Shake well before use. Sterile injection equipment should be used. At least 500 degree days are recommended from vaccination to potential exposure to vibriosis.